None

Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules

WOODCLIFF LAKE, N.J., Oct. 25, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval fro...

Predictors of Basal Cell Carcinoma in High-Risk Patients in the VATTC (VA Topical Tretinoin Chemoprevention) Trial

Suneva acquires Spear product line

Suneva Medical has acquired a new product line, including wordwide rights to Refissa (tretinoin 0.05 percent), from Spear Pharmaceuticals.

Suneva Medical Acquires Product Portfolio from Spear Pharmaceuticals

SAN DIEGO, May 21, 2012 /PRNewswire/ -- Suneva Medical, a privately-held aesthetics company, today announced that it has acquired an aesthetic product portfolio from Spear Pharmaceuticals ("Spear...

Actavis settles with Valeant to launch generic Ziana and Zyclara in USA

US generics drug major Actavis (NYSE: ACT) has reached settlement agreements with Medicis Pharmaceutical, a subsidiary of Canada's Valeant Pharmaceuticals International (TSX: VRX), resolving outstandi...

Galderma's Tri-Luma® Cream, Only FDA-Approved Treatment for Melasma, Now Available in Pharmacies

FORT WORTH, Texas, Feb. 12, 2013 /PRNewswire/ -- Galderma Laboratories, L.P.'s Tri-Luma® (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) Cream, the only FDA-approv...

The Dermatologists in Denver’s Lower Highlands Dermatology at Prima Clinic Are Now Offering Adult Acne Treatment

Denver, CO, July 20, 2012 --(PR.com)-- Lower Highlands Dermatology at Prima Clinic is now offering adult acne treatment. The clinic provides treatment and support for residents that visit from Lakewo...

MEDA: Acnex Approved in Europe

Regulatory News: MEDA (STO:MEDAA): Acnex has received registration approval in Europe via the decentralized procedure. Acnex is a novel product (clindamyc...

Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial.

Keratinocyte carcinoma (KC) is the most common cancer in the United States, with no proven means for prevention other than systemic retinoids, which have significant toxicity, and sunscreen. Topical t...

Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study.

Background: Clinical studies as well as histologic data maintain that tretinoin improves the appearance of photodamage; however, the long-term benefits of tretinoin 0.02% in moderate to severe photoda...

Improved tretinoin photostability in a topical nanomedicine replacing original liquid suspension with spray-dried powder with no loss of effectiveness.

Objective: The use of spray-dried powders containing tretinoin-loaded nanocapsules instead of the original liquid suspension, aimed at the preparation of dermatological nanomedicines with improved pho...

Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin type a.

Background: A hydroquinone (HQ) skin care system has been designed for use in conjunction with nonsurgical procedures. Objective: The authors evaluate the efficacy of this system plus tretinoin for im...

Tretinoin Cyclodextrin Complex (RA/CyD) Causes Less Irritation with an Equal Antiwrinkle Effect Compared with Conventional Tretinoin: Clinical and Histologic Studies of Photoaged Skin.

BACKGROUND: Topical tretinoin [all-trans-retinoic acid (RA)] currently is widely used to treat photoaged skin. However, undesirable side effects such as erythema, irritation, and scaling are unavoidab...